New medicine for people with heart and blood vessel disease
Treatments studied
Part of Heart & circulation clinical trials.
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atherosclerotic cardiovascular disease (ASCVD), which includes conditions like coronary artery disease, peripheral artery disease, or history of stroke.
- Your body mass index (BMI) must be at least 24 (or at least 22 if you have type 2 diabetes).
- You have not had a recent heart attack, stroke, heart failure event, or certain heart procedures in the last 30 days.
- You do not have any serious diabetic complications like severe eye problems, nerve pain, or foot ulcers.
- You have not had pancreatitis, gallstones, or gallbladder disease requiring treatment.
- You can avoid pregnancy or fathering a child, and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.
This trial tests a new medicine called HRS-4029 in healthy people to see how safe it is and how the body handles it. It is an early-stage study that may help in developing a treatment for future patients.
This study tests the long-term safety of the drug HRS-1893 in people with hypertrophic cardiomyopathy who have already been in a previous HRS-1893 study. It helps doctors learn more about how safe the drug is over time.
This study tests a new medicine called SRSD107 for people with long-term blockages in heart or leg arteries. It aims to see if the drug can help prevent clots safely.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
Hear when a new Atherosclerotic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.